UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.

The novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.

For 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.

This advance should facilitate atherosclerosis drug discovery and development.

UAB diabetes expert serves up tailgating hacks to make football season fun and diabetes-friendly.

These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.

In just the five years since UAB completed 10,000 robotic surgeries, surgeons across 15 disciplines have now collectively exceeded 20,000 robotic surgeries, setting a record for the hospital.

Continuous glucose monitors can transform one’s diabetes treatment and care. A UAB diabetes expert explains what patients should know about the devices when evaluating their diabetes care plans.

UAB’s research and reputation land it among the top institutions in the world.

Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.

U.S. News & World report named UAB Hospital as the best hospital in Alabama.

This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.

UAB nutrition experts provide five practical ways you can start living a healthier life.

Benefits of the blood pressure medication verapamil include delayed disease progression, lowered insulin requirements and preservation of some beta cell function.

The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.

Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes.

The drug candidate is a non-toxic small molecule that given orally effectively rescued mice from models of Type 1 and Type 2 diabetes.

Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.